Ticker Symbol: FUSN
Fusion Pharmaceuticals Inc
$6.42 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001805890
Company Profile
Fusion Pharmaceuticals is a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines. Fusion connects alpha particle emitting isotopes to targeting molecules in order to selectively deliver the alpha emitting payloads to tumors. Fusion's lead program, FPI-1434, is currently in a Phase 1 clinical trial. The Company is advancing a pipeline of targeted radiopharmaceutical cancer therapies for a broad array of tumor types based upon its proprietary platform technology.
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Standard Industrial Classification Code (SIC code): 2836
Address: N/A
Website: fusionpharma.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
- Manufacturing
- Biological Product (except Diagnostic) Manufacturing
Pricing
Last Updated: October 13, 2023 03:00 PM EST
Previous Close: $4.13
Change:
$0.41
(
11.02%)
Days Range: $3.64 - $4.17
Beta: 0.20
52wk. High: $5.63
52wk. Low: $1.98
Ytd. Change 42.13%
50 Day Moving Average: $3.11
200 Day Moving Average: $3.76
Shares Outstanding: 68997564
Valuation
Market Cap: 28.5B
PE Ratio: -
EPS (TTM): -1.88
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A